📰 While Enzolytics Inc News
Page 3 - While Enzolytics Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from While Enzolytics Inc. Real-time updates on events, politics, business and more.
March 25, 2022
COLLEGE STATION, TX / ACCESSWIRE / March 25, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/.)In submissions under the Patent Cooperation Treaty (PCT), Enzolytics, Inc. has pending international
March 23, 2022
Press release content from Accesswire. The AP news staff was not involved in its creation.
March 10, 2022
COLLEGE STATION, TX / ACCESSWIRE / March 10, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/) announces that Enzolytics IPF Immune, its immune modulator, will be introduced into the U.S.
February 28, 2022
Enzolytics, Inc. Announces New Advisory Board Member - read this article along with other careers information, tips and advice on BioSpace
January 4, 2022
COLLEGE STATION, TX / ACCESSWIRE / January 4, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/) announces production and sale in the U.S. and North America of "Enzolytics IPF Immune," a
January 4, 2022
Enzolytics, Inc. Announces Production and Sale in North America of “Enzolytics IPF Immune(TM)”, A New Dietary Supplement That Enhances the Immune System - read this article along with other careers information, tips and advice on BioSpace
December 29, 2021
COLLEGE STATION, TX / ACCESSWIRE / December 29, 2021 / Enzolytics, Inc. has engaged Scendea USA, Inc. (www.scendea.com), a leading international product development and regulatory consulting group, to
December 2, 2021
COLLEGE STATION, TX / ACCESSWIRE / December 2, 2021 / Enzolytics wishes to recognize and acknowledge World AIDS Day - a day to call attention to the continued need for a more effective treatment for HIV
July 25, 2021
COLLEGE STATION, TX / ACCESSWIRE / July 20, 2021 / Enzolytics, Inc. (OTC PINK:ENZC) (“Enzolytics” and the ‘Company’) announces the signing of a Letter of Intent (LOI) with Creative Biolabs (“Creative”) (https://www.creative-biolabs.com) to complete the joint production and commercialization of HTLV-1 monoclonal antibodies by combining the technologies of the companies. There are no effective vaccines against HTLV-1 and no antiviral drugs available for treating infections caused by ...
May 26, 2021
COLLEGE STATION, TX / ACCESSWIRE / May 26, 2021 / Enzolytics, Inc. (OTC PINK:ENZC) (the "Company") today announced it has identified conserved, expectedly immutable sites on the HTLV-1 virus against which